A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy
This study has been completed.
Study NCT00271466
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on December 30, 2005.
Last Updated on May 17, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
